![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
(51) | INT.CL. | C07D 473/00 |
(11) | Patento numeris | 1660498 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 04764776.3 |
Europos patento paraiškos padavimo data | 2004-09-02 | |
(97) | Europos patento paraiškos paskelbimo data | 2006-05-31 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2007-08-22 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/EP2004/009819 |
Data | 2004-09-02 |
(87) | Numeris | WO 2005/023811 |
Data | 2005-03-17 |
(30) | Numeris | Data | Šalis |
0320738 | 2003-09-04 | GB |
(72) |
LAWRENCE, Ronnie, Maxwell GlaxoSmithKline, GB
|
(73) |
GLAXO GROUP LIMITED,
Glaxo Wellcome House, Berkeley Avenue,, Greenford, Middlesex UB6 0NN,
GB
|
(54) | PROCESS FOR THE PREPARATION OF (1S,4R)-CIS-4-[2-AMINO-6-CHLORO-9H-PURIN-9-YL]-2-CYCLOPENTENE-1-METHANOL |
PROCESS FOR THE PREPARATION OF (1S,4R)-CIS-4-[2-AMINO-6-CHLORO-9H-PURIN-9-YL]-2-CYCLOPENTENE-1-METHANOL |